Literature DB >> 21849258

A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor.

Konrad Bork1, Karin Wulff, Peter Meinke, Nicola Wagner, Jochen Hardt, Günther Witzke.   

Abstract

In hereditary angioedema with normal C1-inhibitor two different missense mutations of codon p.Thr328* in the coagulation factor 12 gene have been reported in some families. In this study a novel factor 12 gene mutation, the deletion of 72 base pairs (bp) (c.971_1018+24del72*), was identified in a family of Turkish origin, in two sisters with recurrent skin swellings and abdominal pain attacks and in their symptom-free father. This deletion caused a loss of 48 bp of exon 9 (coding amino acids 324* to 340*) in addition to 24 bp of intron 9, including the authentic donor splice site of exon 9. The large deletion of 72 bp was located in the same F12 gene region as the missense mutations p.Thr328Lys* and p.Thr328Arg* reported previously. Our findings confirm the association between F12 gene mutations modifying the proline-rich region of the FXII protein and hereditary angioedema with normal C1-inhibitor.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849258     DOI: 10.1016/j.clim.2011.07.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  24 in total

Review 1.  Wolf in the sheep's clothing: intestinal angioedema mimicking infectious colitis.

Authors:  Asif Mehmood; Hafez Mohammad Ammar Abdullah; Faisal Inayat; Waqas Ullah
Journal:  BMJ Case Rep       Date:  2018-12-13

2.  A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation.

Authors:  Zonne L M Hofman; Chantal C Clark; Wariya Sanrattana; Aziz Nosairi; Naomi M J Parr; Minka Živkovic; Karoline Krause; Niklas A Mahnke; Jörg Scheffel; C Erik Hack; Marcus Maurer; Steven de Maat; Coen Maas
Journal:  J Biol Chem       Date:  2019-11-26       Impact factor: 5.157

3.  Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.

Authors:  Kusumam Joseph; Baby G Tholanikunnel; Bethany Wolf; Konrad Bork; Allen P Kaplan
Journal:  J Allergy Clin Immunol       Date:  2015-09-26       Impact factor: 10.793

4.  Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III.

Authors:  Jenny Björkqvist; Steven de Maat; Urs Lewandrowski; Antonio Di Gennaro; Chris Oschatz; Kai Schönig; Markus M Nöthen; Christian Drouet; Hal Braley; Marc W Nolte; Albert Sickmann; Con Panousis; Coen Maas; Thomas Renné
Journal:  J Clin Invest       Date:  2015-07-20       Impact factor: 14.808

Review 5.  Managing the female patient with hereditary angioedema.

Authors:  Aleena Banerji; Marc Riedl
Journal:  Womens Health (Lond)       Date:  2016-03-15

Review 6.  Genetics of Hereditary Angioedema Revisited.

Authors:  Anastasios E Germenis; Matthaios Speletas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 7.  Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine.

Authors:  Anastasios E Germenis; Matija Rijavec; Camila Lopes Veronez
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-28       Impact factor: 8.667

Review 8.  Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene.

Authors:  Jyoti Sharma; Ankur Kumar Jindal; Aaqib Zaffar Banday; Anit Kaur; Amit Rawat; Surjit Singh; Hilary Longhurst
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-14       Impact factor: 8.667

9.  In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency.

Authors:  A L Manson; A Price; J Dempster; P Clinton-Tarestad; C Greening; R Enti; S Hill; S Grigoriadou; M S Buckland; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

Review 10.  Biomarkers in Hereditary Angioedema.

Authors:  Grzegorz Porebski; Mateusz Kwitniewski; Avner Reshef
Journal:  Clin Rev Allergy Immunol       Date:  2021-02-09       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.